Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

7.7%

2 terminated/withdrawn out of 26 trials

Success Rate

84.6%

-1.9% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 11 completed trials have results

Key Signals

9 recruiting

Enrollment Performance

Analytics

N/A
4(57.1%)
Phase 2
3(42.9%)
7Total
N/A(4)
Phase 2(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (26)

Showing 20 of 26 trials
NCT05047315Completed

Evaluating a New Stool Based qPCR for Diagnosis of Tuberculosis in Children and People Living With HIV

Role: collaborator

NCT07386912Not Yet Recruiting

Investigation of the Effects of Oxidized Antigens on the T-Cell Response and the Epigenetic Reprogramming of Neutrophils in Lung Diseases - OXIGENE -

Role: lead

NCT07369414Recruiting

Environmental Reservoirs of Non-tuberculous Mycobacteria in Cystic Fibrosis Households: A Case-control Study of Exposure Risk at Home

Role: lead

NCT06114628Phase 2Recruiting

Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB

Role: collaborator

NCT07131774Recruiting

Treatment Monitoring for NTM Infections With a Symptom Diary

Role: lead

NCT07125274Recruiting

Sputum-free Diagnostis of TB

Role: lead

NCT06909799Not ApplicableRecruiting

A Confirmatory Trial of Adjunctive NAC to Prevent Post Tuberculosis Lung Disease

Role: collaborator

NCT06875336Recruiting

A Multicentric Cohort and Biomarker Study for Improved Care of Patients with Extrapulmonary Tuberculosis

Role: collaborator

NCT06815588Recruiting

Improving the Outcomes of Children With Tuberculosis Through Innovative Diagnostics and Treatment Monitoring

Role: lead

NCT05268380Completed

Collision of Three Global Pandemics: the Effect of Tuberculosis and HIV on the Epidemiological, Clinical, Virological and Immunological Trajectory of COVID-19 in Botswana and Namibia

Role: collaborator

NCT05022238Recruiting

Hotspots, Households and Hospitals: Enhanced Drug-resistant Tuberculosis Case Finding in Namibia

Role: collaborator

NCT03562442Not ApplicableCompleted

SAW Lung Microbiome Study in Smokers and Never-smokers

Role: lead

NCT03299764Not ApplicableSuspended

Evaluation of Non-invasive Pursed-lip Breathing Ventilation (PLBV) in Advanced COPD

Role: lead

NCT02413931Completed

Nosocomial Transmission of MDR-TB in Bucharest, Romania

Role: lead

NCT02597621Completed

Biomarkers for Therapy Response in Drug-resistant Tuberculosis

Role: lead

NCT04783727Not ApplicableTerminated

PredictEndTB Signature for Individualizing Treatment in Multidrug-Resistant Tuberculosis

Role: lead

NCT02419274Recruiting

Adult Arm of DZL All Age Asthma Cohort (ALLIANCE)

Role: collaborator

NCT03734172Completed

Rapid and Accurate Diagnosis of Paediatric TB (RaPaed-AIDA-TB)

Role: collaborator

NCT03251196Unknown

TB Sequel: Pathogenesis and Risk Factors of Long-term Sequelae of Pulmonary TB

Role: collaborator

NCT03416309Unknown

Personalization of AntiTB Treatment: Evaluation of Pharmacological Determinants of Treatment Response

Role: collaborator